Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion SR in Elderly Patients with Depression
NCT00330616Phase 2Completed
- Sponsor
- GSK
- Start
- May 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in major depressive disorder (MDD), sponsored by GSK. Started May 2006; status: completed.
02
Drugs
bupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00330616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330616.